Extramedullary Relapse of Acute Promyelocytic Leukaemia (APL) at an Unusual Site (External Auditory Canal)

EJHaem Pub Date : 2025-03-06 DOI:10.1002/jha2.70013
Prathima Iyer, Carole Hudson, Kanwar Sohail, Loredanna Mihailescu, Simon Bolam
{"title":"Extramedullary Relapse of Acute Promyelocytic Leukaemia (APL) at an Unusual Site (External Auditory Canal)","authors":"Prathima Iyer,&nbsp;Carole Hudson,&nbsp;Kanwar Sohail,&nbsp;Loredanna Mihailescu,&nbsp;Simon Bolam","doi":"10.1002/jha2.70013","DOIUrl":null,"url":null,"abstract":"<p>A 55-year-old lady diagnosed with APL-M3 variant in 2021 and treated with AIDA regimen to complete remission (CR1) and negative MRD. She maintained MRD negative results at 3 months post treatment.</p><p>Six months after treatment, she presented with persistent feeling of blocked right ear canal and otalgia. She had an inflamed right ear canal and difficulties to visualise the right tympanic membrane due to a polypoidal lesion. She did not respond to initial antibiotic treatment and had progressed to decreased auditory acuity with persistent ear pain and development of right cervical and periauricular lymphadenopathy.</p><p>Her blood counts were within normal range at this time. MRI head demonstrated in FLAIR coronal (Figure 1A) and T2 axial (Figure 1B) images, a soft tissue in right external auditory canal. The biopsy of this mass showed monomorphic cells with high nucleocytoplasmic ratio. On immunohistochemistry, these were positive for CD117(C), MPO (D), CD33 and CD68. A contemporaneous bone marrow biopsy was in morphological remission, however the flowcytometry found a population of CD33, CD117 and MPO positive cells and positive MRD of 18.5%. Cytogenetics (E) showed ongoing presence of the t (15, 17). She had a lumbar puncture and flowcytometry results of CSF analysis ruled out CNS involvement.</p><p>She commenced arsenic and ATRA treatment and achieved PET and bone marrow remission post induction. She continued with 3 further consolidation cycles, followed by consolidation with an autologous stem cell transplant and at D+100 continues to be MRD negative in bone marrow and radiological remission on PET.</p><p>This is an unusual extramedullary relapse of APL (external auditory canal), while the blood counts were normal and bone marrow was in morphological remission. This reiterates the importance of MRD monitoring and low threshold to investigate unusual or persistent auditory symptoms, as these may be the first presentation of relapse of the disease. Extramedullary relapse is infrequent in APL and relapse in auditory canal has been reported as an unusual site of relapse [<span>1, 2</span>], considering that usually the extramedullary relapses happen in skin or CNS.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":72883,"journal":{"name":"EJHaem","volume":"6 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jha2.70013","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJHaem","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jha2.70013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A 55-year-old lady diagnosed with APL-M3 variant in 2021 and treated with AIDA regimen to complete remission (CR1) and negative MRD. She maintained MRD negative results at 3 months post treatment.

Six months after treatment, she presented with persistent feeling of blocked right ear canal and otalgia. She had an inflamed right ear canal and difficulties to visualise the right tympanic membrane due to a polypoidal lesion. She did not respond to initial antibiotic treatment and had progressed to decreased auditory acuity with persistent ear pain and development of right cervical and periauricular lymphadenopathy.

Her blood counts were within normal range at this time. MRI head demonstrated in FLAIR coronal (Figure 1A) and T2 axial (Figure 1B) images, a soft tissue in right external auditory canal. The biopsy of this mass showed monomorphic cells with high nucleocytoplasmic ratio. On immunohistochemistry, these were positive for CD117(C), MPO (D), CD33 and CD68. A contemporaneous bone marrow biopsy was in morphological remission, however the flowcytometry found a population of CD33, CD117 and MPO positive cells and positive MRD of 18.5%. Cytogenetics (E) showed ongoing presence of the t (15, 17). She had a lumbar puncture and flowcytometry results of CSF analysis ruled out CNS involvement.

She commenced arsenic and ATRA treatment and achieved PET and bone marrow remission post induction. She continued with 3 further consolidation cycles, followed by consolidation with an autologous stem cell transplant and at D+100 continues to be MRD negative in bone marrow and radiological remission on PET.

This is an unusual extramedullary relapse of APL (external auditory canal), while the blood counts were normal and bone marrow was in morphological remission. This reiterates the importance of MRD monitoring and low threshold to investigate unusual or persistent auditory symptoms, as these may be the first presentation of relapse of the disease. Extramedullary relapse is infrequent in APL and relapse in auditory canal has been reported as an unusual site of relapse [1, 2], considering that usually the extramedullary relapses happen in skin or CNS.

The authors declare no conflicts of interest.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Issue Information Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case report Extramedullary Relapse of Acute Promyelocytic Leukaemia (APL) at an Unusual Site (External Auditory Canal) Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United States Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1